Overview

Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of ramelteon, once daily (QD), combined with doxepin in treating subjects with insomnia.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda
Treatments:
Doxepin